Skip to main content
. 2022 Feb 9;9(2):1492–1495. doi: 10.1002/ehf2.13837

Table 2.

The individual and sequential impact of each eligibility criterion according to VICTORIA in KorAHF registry population with complete information for eligibility assessment

VICTORIA criteria Prevalence
Individually (%) Sequentially (%)
1. Age ≥18 years 100%
2. LVEF ≤ 45% 100%
3. Prior HF hospitalization within 6 months 100%
4. SBP ≥ 100 mmHg 78.1% 78.1%
5. Elevated natriuretic peptide a 79.9% 62.2%
6. eGFR ≥ 15 mL/min/1.73 m2 94.9% 58.0%
7. eGFR ≥ 30 mL/min/1.73 m2 88.2% 52.5%

BNP, B‐type natriuretic peptide; eGFR, estimated glomerular filtration rate; HF, heart failure; KorAHF, Korean Acute Heart Failure registry; LVEF, left ventricular ejection fraction; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; SBP, systolic blood pressure; VICTORIA, Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction.

a

BNP ≥ 300 pg/mL or NT‐proBNP ≥ 1000 pg/mL for sinus rhythm and BNP ≥ 500 pg/mL or NT‐proBNP ≥ 1600 pg/mL for atrial fibrillation.